| Effect of Phenylalanine-arginine-beta-naphthylamide to Ciprofloxacin Minimum Inhibitory Concentration Values and Expression of Efflux Pump System Genes in Acinetobacter baumannii Isolates | Fatma KAYNAK ONURDAĞ,Uğur KAYIŞ,Suzan ÖKTEN | 285–299 |
| Friend or Foe? Evaluation of BCG Vaccine and Latent Tuberculosis Infection Effect in Patients Diagnosed with COVID-19 Infection | Hüseyin Aytaç ERDEM,Gamze ŞANLIDAĞ,Müyesser Ece ÇINAR,Melike YAŞAR,Hüsnü PULLUKÇU,Meltem TAŞBAKAN IŞIKGÖZ,Cengiz ÇAVUŞOĞLU,Deniz GÖKENGİN,M. Sezai TAŞBAKAN | 300–310 |
| Analysis of Nucleotide Changes in RT-PCR Primer/Probe Binding Regions in SARS-CoV-2 Isolates Reported from Turkey | Ayşe Banu DEMİR,Alihan BULGURCU,Özgür APPAK,Ayça Arzu SAYINER | 311–326 |
| Bleeding Risk Score in Patients with Crimean-Congo Hemorrhagic Fever | Ömer KARAŞAHİN,Emine Fusun SAHİN | 327–341 |
| Clinical Characteristics of Mild-Moderate COVID-19 Patients and Risk Factors for the Development of Pneumonia | Yusuf Emre ÖZDEMİR,İlker BALKAN,Osman Faruk Bayramlar,Sena ALKAN,Ahmet MURT,Rıdvan KARAALİ,Bilgül METE,Mert Ahmet KUŞKUCU,Gökhan AYGÜN,Yılmaz KESKİNDEMİRCİ,Şeniz ÖNGÖREN,Zekayi KUTLUBAY,Oğuz ÇETİNKALE,Neşe SALTOĞLU,Fehmi TABAK | 342–356 |
| Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic | Hatice Hale GÜMÜŞ,Yusuf Ziya DEMİROĞLU,Hikmet Eda ALIŞKAN,İlker ÖDEMİŞ,Özgür CEYLAN,Ahmet Gürhan POÇAN,Özlem KARAGÜN | 357–373 |
| Investigation of the Relationship Between IL28B Polymorphisms and Plasma IL28B Levels in Patients with Chronic Hepatitis B or C | Zeynep KOÇ KURALAY,Esra TUĞ,Işıl FİDAN | 374–388 |
| Evaluation of Non-Pharmaceutical Interventions for Reducing Contact Rate in COVID-19 Pandemic: $R_0$ Estimation and Modeling for Istanbul | Işıl MARAL,Emine YAYLALI,Hasan GÜÇLÜ,Hatice İKİIŞIK,Abdullah Emre GÜNER | 389–405 |
| The Role of Vitamin D3 on the Immune Responses of Monocytes | Derya BİRİKEN,Pelin ARIBAL AYRAL,Nuray YAZIHAN | 406–414 |
| Investigation of the Clinical Significance of Anti-Dense Fine Speckled 70 (anti-DFS70) Autoantibody and Determination of Accompanying Pathologies |